- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01620281
The Efficacy of the no!no!Back for Chronic Low Back Pain (LBP-1)
The no!no!Back Continuous Passive Motion Device for the Treatment of Chronic Low Back Pain: A Randomized Controlled Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The no!no!Back is an electrically operated, continuous passive motion device including a platform that performs angular oscillations. The device is intended to be used at home as an accessory for relieving of mild to moderate low back pain (LBP).
This study is designed to determine the efficacy of daily use home use with the no!no!Back device during 3 weeks and to assess the sustained effect 3 weeks later. Up to 30 subjects will be randomized to either an immediate treatment (IT) group that will receive the no!no!Back device at the baseline visit, or to the wait-list control (WLC) group that will receive the device 3 weeks later. The evaluation will include level of pain using the numerical rating scale (NRS), functional health status by Oswestry disability index (ODI), and subject satisfaction.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mevasseret-Zion, Israel
- Koren Physiotherapy Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female, age 18 or more
- Level of pain - mild to moderate low back pain (≤5 NRS pain)
- Chronic - symptoms must have been present for at least 12 weeks or more.
- Location - lower tip of scapula to back of pelvis
- Etiology - non-specific
Exclusion Criteria:
- Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome).
- Pregnant or lactating
- Recent history of violent trauma
- History of previous back surgery
- Constant progressive, non mechanical pain (no relief with bed rest)
- Chronic pain other than low back pain
- Past medical history of malignant tumour
- Has taken an investigational drug within the past 30 days prior to entering the study, or currently enrolled in another investigational study
- Mental disorder that would lead to difficulty in questionnaire completion
- Current or future litigation for low back pain
- Prolonged use of corticosteroids
- Physical disability that prevents the subject to lie down/get up
- Drug abuse, immunosuppression, HIV
- Any other condition which in the physician's opinion would make it unsafe for the subject to be treated.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate treatment (IT)
Subjects from this group will receive the device immediately.
Subjects will be instructed to treat themselves daily for 3 weeks, in up to three 10-minutes sessions.
All subjects will receive a diary to record details of the daily use of the device (time of day, position of legs, and number of daily uses), degree of pain, a weekly ODI questionnaire, and record of any back/pain related events.
After 3 weeks the subjects from the IT group will return the device and at 6 weeks they will visit again for the final evaluation.
|
Self treatments daily for 3 weeks, in up to three 10-minutes sessions
|
Other: Waiting List Control (WLC)
The WLC group will go through the same evaluations at the same time intervals but will begin treatments 3 weeks later during which they will fill the diary daily but not use the device.
|
Self treatments daily for 3 weeks, in up to three 10-minutes sessions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in pain level after 3 weeks compared to baseline (before treatment)
Time Frame: 3 weeks
|
Pain level will be scored by the subject using a numerical rating scone on a 0 to 10 scale where 10 represents the highest degree of pain and 0 represents a complete lack of pain
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in functional health status by ODI
Time Frame: 3,6 weeks
|
Functional health status will be determined by the ODI questionnaire filled by the subject (10 multi-choice questions, takes 5 minutes to answer).
|
3,6 weeks
|
Subject satisfaction
Time Frame: 6 weeks
|
The subject will be verbally asked to grade his/her overall satisfaction according to the satisfaction assessment scale based on a 5-point Likert scale detailed in Table 3 where 0 represents very unsatisfied and 4 represents very satisfied.
In addition the subject will fill a questionnaire.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LBP-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild to Moderate Chronic Low Back Pain
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Iran University of Medical SciencesNot yet recruitingLow Back Pain | Chronic Low-back Pain | Chronic Non-specific Low Back Pain | Cupping Therapy
-
Norton Leatherman Spine CenterUnknownLow Back Pain Unresponsive to Non-surgical CareUnited States
-
Federal University of Minas GeraisRecruitingBack Pain | Low Back Pain | Chronic Low-back Pain | Back Pain Lower Back ChronicBrazil
-
University of Colorado, BoulderNational Institutes of Health (NIH); Radiological Society of North America; Psychophysiologic... and other collaboratorsCompletedChronic Pain | Back Pain Lower Back Chronic | Back Pain, LowUnited States
-
Presidio Medical, IncRecruitingChronic Pain | Chronic Low-back PainAustralia
-
Rush University Medical CenterDuke University; University of Alabama, TuscaloosaCompleted
-
Inbo HanEnrolling by invitationPatients With Chronic Low Back Pain Due to Degenerative Lumbar DiscKorea, Republic of
Clinical Trials on no!no!Back
-
University of California, San FranciscoNational Cancer Institute (NCI); National Institutes of Health (NIH)Not yet recruitingColorectal Cancer | Colon Cancer | Cancer ColorectalUnited States
-
The Hong Kong Polytechnic UniversityRecruitingChronic Low Back PainHong Kong
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of California, Santa BarbaraCompleted
-
HealthpointCompletedVenous Leg Ulcer (VLU)Germany, Poland, Belgium, Hungary, Czechia
-
RTI InternationalNo Means No WorldwideCompleted
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Fraunhofer-Institute of Toxicology and Experimental...UCB PharmaCompleted
-
Yonsei UniversityCompletedAdult Patients Undergoing Surgery That Requires General AnesthesiaKorea, Republic of